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Background: Yunnan Province is a multi-ethnic area located in the southwest of China, and she also is rich in Chinese matiera medica resources, known as the 'kingdom of plants'. Background Fossil records date human use of plants as medicines at least to the Middle Paleolithic age some 60,000 years ago [1] . Through the long and slow clinical trial and error-based use of botanicals and other biomaterials in history [2] , Individuals in different civilization in the world had built their traditional medical knowledge systems based on local medicinal resources, and varieties of traditional medical systems had been formed. Until now, herbal medicines serve the health needs of about 80% of the world's population, especially for millions of people in the vast rural areas of developing countries, according to the reports of the world health organization (WHO) [3] . The Chinese are known to have one of the oldest and distinct medical systems in the world, named Traditional Chinese Medicine (TCM), spanning a written history of nearly 3000 years, widely accepted in China [4] . China is a multi-racial country with 56 nationalities, of which 55 in over 18 provinces are officially recognized as ethnic minorities. Every ethnic minority has its own traditional medicine and there are many medical traditions practiced by Tibetan, Mongol, Uygur, Dai, Yi, Miao, and other ethnic minorities in China that differ slightly in theory and in practice from TCM. Yunnan Province is located in the southwest of China and she belongs to a multinational area. According to statistics, apart from the Han nationality, there are 25 ethnic minorities with a population of more than 6,000, including Yi, Hani, Bai, Dai, Zhuang, Miao, Hui, Tibetan and other ethnic minorities, and the population of ethnic minorities has reached 16 .0337 million, 33.4% of the total population of Yunnan Province. Dai Medicine, Yi Medicine and Tibetan Medicine are the representatives of ethnomedicine in Yunnan, which are accepted by the common people and own their traditional medical theories and independent hospitals. Except Tibetan Medicine in Shangri-La, which will be reported specially in another paper, Yunnan Province is the important pharmaceutical industrial base for Dai Medicine and Yi Medicine in China. For example, the most famous drug named as Yunnan Baiyao, a Yi medical formula with "amazing efficacy", is well known worldwide [5] . According to report, the biomedicine and big health industry have been the pillar industry of Yunnan since 2016. There are more than 2000 ethnic medicinal resources and more than 10,000 folk prescriptions in Yunnan [6] , and taking Dai Medicine and Yi Medicine as representatives, ethnic medicine will be the innovative development path for modern Chinese Medicine and modern medicine from natural products.
In a previous studies,the investigation on Ethnic patent medicine (EPM) in the Chinese Pharmacopoeia (2015 Edition) shows that some herbal medicine (here, herbal medicines refer to not only plants but also animals and minerals with effects of treatments) composed in EPMs are lack of national quality standards. There are 71 herbs not collected in Chinese Pharmacopoeia, which are used in 39 EPMs [7] . This phenomenon is called 'standard upside down', which will affect the safety of Chinese patent medicine (CPM) and healthy development of Chinese pharmaceutical industry. Therefore, it is necessary to have a more comprehensive understanding of ethnic medicine. On the other hand, the fourth national survey on Chinese matiera medica resources is in progress in China, and the main tasks of which are to master the basic situation of Chinese matiera medica resources and to explore fully the modern value of herbal medicine knowledge including ethnic medicine and folk medicine, strengthening the construction of Chinese materia medica resources [8] . Yunnan is rich in Chinese matiera medica resources, known as the 'kingdom of plants'. In view of this, this paper will focus on the ethnic medicine industry and investigate Yi medicine and Dai medicine of Yunnan Province; it includes the basic information of Dai patent medicine (DPM) and Yi patent medicine (YPM), the quality standards of the constituent herbal medicines and the use of rare and endangered resources, toxic herbs and other aspects.
Methods

Data sources
This study focused on the development status of ethnic pharmaceutical industry, especially Yi Medicine and Dai Medicine in Yunnan Province. The review work was dependent on the published literatures (Table 1 ) and some medical information from public service websites (Table 2 ). These contents were of interest to us, which include: (1) quantities of CPM from Yi Medicine and Dai Medicine produced by pharmaceutical companies in Yunnan Province; (2) the disease types that these CPM could be used to 
Rare and Endangered Plant Information Service Platform in China
Investigation
In order to achieve these objectives, these methods were accepted and used as follows: 
Results
Surveys and Statistics on the varieties and clinical indications of DPM and YPM in Yunnan
Province
The CPMs were surveyed and counted, on the basis of ethnic medicine formula preparation of China or the pharmaceutical instructions in which their properties of ethnic medicine were claimed. The results showed that there were 28 varieties of DPMs (Table 3)and 73   varieties of YPMs Table 4 , which could be approved to use in clinical according to the drug regulatory laws of China. In the DPMs, 15 varieties of prescriptions such as Biao Re Qing Granular, Guan Tong Shu Oral liquid, Hui Xue Sheng Capsule, have been approved as the over-the-counter drugs (OTC), accounting for 53.57% of the total DPMs, while in the YPMs, 28 varieties of prescriptions such as Bai Bei Yi Fei Capsule, Chang Shu Zhi Xie Capsule, Dan E Fu Kang Ointment, have be approved as OTC drugs, accounting for 37.83% of the total YPMs. In the statistics of clinical indications of these EPMs, it is found that the DPMs and YPMs are used to treat respiratory diseases, cardiovascular diseases, mental and neurological diseases etc quality of stroke patients with cerebral infarction [9] . And DDTN could prevent cerebral injury of MCAO rats via decreasing the intracellular Ca 2+ concentration, and inhibiting the release of excitatory amino acids [10] . [11] . Besides, the academy group standards and enterprise standards also play the role in quality standards of ethnic medicines. In this study, it was found that in the total 28
DPMs, quality standards of 109 herbal medicines come from Chinese pharmacopoeia; In the frequency statistics of herbal medicines used in these prescriptions, the total frequency and frequency in DPMs and YPMs were calculated out ( Fig. 4 Table 5 . animal medicines and 9 mineral medicines used in DPMs and YPMs (Fig. 5 ). It is an interesting discovery that the number of animal medicines in YPMs is more than that in DPMs. The Yi Nationality as excellent hunters with a long history, were adept in using animal medicines, which is proved with many ancient documents. In Yi Nationality Offering [12] .
Indeed, animals are therapeutic arsenals that have been playing significant roles in the healing processes, which are also known as zootherapy. Animal medicines have been elaborated from parts of the animal bodies, from products of their metabolism (corporal secretions and excrements), or from non-animal materials (nests or cocoons) [13] .Since the pertinence of traditional medicine based on animals cannot be denied, animal medicines used in CPM should be strengthened modern scientific research. The animal medicines in DPMs and YPMs were set out in Table 6 . 
Medicinal parts of botanical medicines used in DPMs and YPMs
The plant parts used in herbal therapy include seeds, berries, roots, leaves, fruits, barks, flowers, or even the whole plants. From ancient times to the present, people have been mainly dependent on crude botanical material for medical needs to retain vitality and cure diseases [14] . In this work, we have analyzed amount of medicinal parts of botanical medicines in DPMs and YPMs (Fig. 6) [15] .
Surveys and Statistics on the rare and endangered medicinal materials in DPMs and YPMs in Yunnan Province
The rapidly increasing demand for Chinese patent drugs is likely to challenge herbal resources in China. Consequently 80% of the most usually used species cannot meet medical demand [16] . Data analysis showed that 1,800-2,100 medicinal species were facing the challenge of extinction in China [17] .In the China Plant Red Data Book published in 1992, 388 species of plants are listed as threatened, which include 121 as endangered(i.e., first grade national protection), 110 as rare (second grade national protection), and 157 as vulnerable (third grade national protection). Among these plant species, 77 are typical herbal medicines that account for 19.86% of the total threatened species [18] .Besides, 257 kinds of animal medicines appear in the national key protection name list of wild animals. Although the shortage of medicinal materials is alleviated to some extent since more than 200 kinds of herbs could be artificially planted, for [19] .In light of this, 30 herbal medicines were listed to protect in the Rare Traditional Chinese Herbs of Yunnan Province in Urgent Needs (RTCHYN) [20] . These herbs used in DPMs and YPMs were summarized in Table 8 . Oliv.
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Surveys and Statistics on the toxic herbal medicines in DPMs and YPMs in Yunnan Province
In traditional medicine of ethnic minorities, herbs with pharmacological activity are likely to be clinically useful, but may also be toxic, especially if used incorrectly or do not master the correct use method. Different from modern drugs, efficacy and toxicity assessments of herbal medicines are based on traditional knowledge and clinical experience rather than evaluation in a laboratory [21] . The causes of toxic medicine usage in Chinese ethnomedicine are related with living environments, religious belief and medical practices concerned with poisons. In China, 83 herbal medicines are officially recorded and defined as toxic according to the Chinese Pharmacopoeia and the certain number of toxic herbs is also recorded in provincial standards for herbal medicine. Toxic herbal medicines are classified into three categories: high toxicity, medium toxicity, and low toxicity [22] . According to the statistics, there are 10 toxic herbs used in 11 DPMs, and 6 toxic herbs recorded in Chinese Pharmacopoeia and 4 toxic herbs recorded in SYNP.
Among them, 1 herb is called Dai medicine and 2 herbs belong to Yi medicine. In the 40
YPMs, the toxic herbs are counted to 24, and the number of 12 toxic herbs is collected in Chinese Pharmacopoeia, 12 herbs recorded in SYNP. 4 herbs are known as Yi medicine.
These results are showed in Table 9 and Table 10 . Although some toxic herbs used in DPMs and YPMs, these proprietary medicines are considered safe and applied in clinical legally in China because of the unique set of pharmaceutical theories that include particular methods for processing, combining and decocting,which contribute to reducing toxicity as well as enhancing efficacy.For example, in traditional Dai medicine(TDM), the herbs used to reduce poison of toxic herbs are called "YaGei", and "YaGei" theory (YGT or Detoxification theory) is considered as aunique supplementary theory of TDM [23] . The Dai herbal medicines named "YaGei" as antidotes could relieve all kinds of adverse reactions caused by food poisoning, drug poisoning and other substances [24] .Besides, in order to keep healthy, Dai people also take antidotes regularly to eliminate the micro toxins in the body, and thus reduce the chance of illness and prolong life.
Due to the lack of more pharmaceutical information disclosed, as well as the lack of basic research, the safety information of these DPMs and YPMs including toxic herbal medinces is insufficient. The modern toxicological evidences of these toxic herbal medicines were collected and also showed in Table 9 and Table 10 . Our focus is on these toxic herbal medicines which are known as Dai medicines or Yi medicines. Root of Tripterygium hypoglaucum (LevL.)Hutch (Huobahuagen, ) soaked in wine as oral medicine was recorded in AilaoMateria Medica( ), a book translated and published according to ancient Yi medicine classics,and could be used to treat the arthritis, joint swelling and pain, bruise and sprain [25] . [26] . In fact, more evidence in ancient documents would be researched deeply to record the application of these toxic herbs in the medical practice of Yi, Dai or other ethnic minorities in Yunnan. While modern toxicology experiments have provided more toxicity information of these toxic herbs, which are benefit to use them safely and cautiously. Of course, more scientific research are necessary to identify how these toxic herbs reduce the toxicity and remain effective in the prescriptions.
Discussion
Ethnomedicine is the important part of traditional Chinese medicine, which has formed its own unique medical theoretical system. During the course of thousands of years of ethnic [7] . Furthermore, annual growth of more than 15% and traditional Chinese medicine including ethnic medicine and natural products account for 75% until 2020 [54] . The conclusions could be obtained from this investigation on Dai medicine and Yi medicine, and we summarized them into 5 aspects.
(1) Except Yunnan Baiyao Group Co., Ltd. and Dihon Pharmaceutical Co. Ltd, most of pharmaceutical enterprises of Yunnan Province for EPMs are small in the production scale, which lead to the limit on abilities of research and development on EPMs. We searched the number of publications of DPMs in CNKI (www.cnki.net), and until now the total number of 163 articles about these 28 DPMs has been published, while the number of documents about Yunnan Baiyao Aerosol has reached 59. It should be known that Yunnan Baiyao Aerosol is only one of CPMs produced by Yunnan Baiyao Group Co., Ltd., and just in 2015, 100 million bottles of Yunnan Baiyao Aerosol were produced, its output value exceeded 1.5 billion RMB. In the same year, the overall sales revenue of Yunnan Baiyao Group Co.,
Ltd. already achieved 20.74 billion RMB [5] .
(2) Although it could not be acquired about the sales volume of YPMs and DPMs, and whether the herbal sources used in YPMs and DPMs are from wild collection, from the usage frequency in YPMs and DPMs, Ganca, Sanqi and Dengzhanxixin have a high proportion in YPMs and DPMs. The challenges of these herbal resources for sustainable utilization have been discussed before.
(3) The use of toxic herbal medicine is always affecting people's worries about the safety of TCM. Aristolochic acid nephropathy in Belgium and the adverse events of Xiao Chaihu Tang in Japan are the warning of the safety of CPM. More scientific evidence is needed to prove the rationality and necessity of using toxic herbs in EPMs.
(4) In the medical practice and the process of identifying and using herbal medicine, every ethnic minority mastered and formed their own experiences of using herbs. In this study, the characteristics of using animal medicines by Yi people were found out through the surveys and statistics on the herbal resources in DPMs and YPMs. And it also is certificated by the ancient medical literature of Yi minority.
(5) The usage methods of Dai and Yi medical prescriptions were recorded with Dai and Yi language historically; the clinical indications DPMs and YPMs are described with Chinese language. It is difficult to master more accurate usage information of DPMs and YPMs because of translation and it will be the next important work.
Conclusions
In the investigation, we can't get the selling information of these DPMs and YPMs because it's a trade secret for the enterprise, which affect our access to collect more information 
